Seagen (SGEN) Announces ADCETRIS Combination Significantly Improves Overall Survival in Newly Diagnosed Patients with Advanced Hodgkin Lymphoma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. DELL
7. NIO
8. ENOV
9. AON
10. A

Go back to Seagen (SGEN) Announces ADCETRIS Combination Significantly Improves Overall Survival in Newly Diagnosed Patients with Advanced Hodgkin Lymphoma
Seattle Genetics Inc /wa (NASDAQ: SGEN) Delayed: 228.74 --0 (-0%)
Previous Close $228.74    52 Week High $75.36 
Open $22.94    52 Week Low $26.02 
Day High $228.74    P/E N/A 
Day Low $228.74    EPS $-0.51 
Volume 759,302